InvestorsHub Logo
Followers 897
Posts 149188
Boards Moderated 0
Alias Born 08/13/2010

Re: kei post# 7468

Monday, 10/28/2019 8:42:45 AM

Monday, October 28, 2019 8:42:45 AM

Post# of 7536
Bionano Genomics, Inc. $BNGO is a life sciences instrumentation company in the genome analysis space. The Company develops and markets the Saphyr system. The Company's products include Sequencing for Discovery Research and Cytogenetics. Sequencing alone, however, is significantly limited due to its inability to reveal structural variations. Cytogenetics provide a clinical diagnosis, cytogenetic tests detect known variations that are linked to specific diseases or therapeutic responses. Saphyr system is platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Sequencing for Discovery Research is primarily used to find single nucleotide variations responsible for disease or therapeutic response.
Company Contact

Headquarters

9540 Towne Centre Dr Ste 100
San Diego, CA 92121-1989

https://bionanogenomics.com/

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.